Oarsman Capital, Inc. Vertex Pharmaceuticals Inc Transaction History
Oarsman Capital, Inc.
- $533 Million
- Q3 2024
A detailed history of Oarsman Capital, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Oarsman Capital, Inc. holds 4,123 shares of VRTX stock, worth $1.67 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
4,123
Previous 5,076
18.77%
Holding current value
$1.67 Million
Previous $2.38 Million
19.42%
% of portfolio
0.36%
Previous 0.53%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.39 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.64 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.79 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.65 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $104B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...